Michael Eissenstat
26Patents
4h-index
26Co-inventors
59Inventor score
Filing activity: Sep 28, 2001 → Jan 11, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9403789B2 | Benzofuran-containing amino acid inhibitors of cytochrome P450 | Chemistry; Metallurgy | 19 | Active |
| US6649651B1 | Hexahydrofuro[2,3-B]furan-3-yl-n{3[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor | Human Necessities | 9 | Expired |
| US7109230B2 | Resistance-repellent retroviral protease inhibitors | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7285566B2 | Resistance-repellent retroviral protease inhibitors | Physics | 4 | Expired |
| US6613764B1 | Aspartic protease inhibitors | Chemistry; Metallurgy | 4 | Expired |
| US7157495B2 | Hexahydrofuro[2,3-B]furan-3-YL-N-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor | Human Necessities | 3 | Expired |
| US8673970B2 | HIV protease inhibitor and cytochrome p450 inhibitor combinations | Human Necessities | 3 | Active |
| US7981929B2 | Benzofuran derived HIV protease inhibitors | Human Necessities | 3 | Active |
| US8906647B2 | Diamide inhibitors of cytochrome P450 | Emerging Cross-Sectional Technologies | 2 | Active |
| US7507763B2 | Resistance-repellent retroviral protease inhibitors | Human Necessities | 2 | Active |
| US8048871B2 | Compositions and methods for inhibiting cytochrome P450 | Chemistry; Metallurgy | 2 | Active |
| US7378441B2 | Resistance-repellent retroviral protease inhibitors | Human Necessities | 2 | Expired |
| US8765667B2 | HCV protease inhibitors | Chemistry; Metallurgy | 2 | Active |
| US7807845B2 | Resistance-repellent retroviral protease inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8389571B2 | Benzofuran derived HIV protease inhibitors | Human Necessities | 1 | Active |
| US9540354B2 | Diamide inhibitors of cytochrome P450 | Emerging Cross-Sectional Technologies | 1 | Active |
| US8791157B2 | 5-substituted benzofurans as inhibitors of cytochrome P450 2D6 | Chemistry; Metallurgy | 1 | Active |
| US8481520B2 | Compositions and methods for inhibiting cytochrome P450 | Chemistry; Metallurgy | 0 | Active |
| US8569364B2 | 5-substituted benzofurans as inhibitors of cytochrome P450 2D6 | Chemistry; Metallurgy | 0 | Active |
| US7429677B2 | Small molecule entry inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US8952056B2 | Methods for inhibiting drug degradation | Human Necessities | 0 | Active |
| US8703700B2 | Bimacrocylic HCV NS3 protease inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9604952B2 | Compositions and methods for inhibiting cytochrome P450 2D6 | Chemistry; Metallurgy | 0 | Active |
| US9849107B2 | Compositions and methods for inhibiting cytochrome P450 | Chemistry; Metallurgy | 0 | Active |
| US7132420B2 | Aspartic protease inhibitors | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.